Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer’s disease clinical program-Reference-Cited by-同舟云学术

Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer’s disease clinical program

Published:2018-11-24 Issue:1 Volume:10 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Cummings Jeffrey L.,Atri Alireza,Ballard Clive,Boneva Neli,Frölich Lutz,Molinuevo José Luis,Raket Lars Lau,Tariot Pierre N.

Funder

H. Lundbeck A/S

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-018-0443-2.pdf

Reference36 articles.

1. Alzheimer’s Association. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement. 2016;12:459–509.

2. Atri A. Effective pharmacological management of Alzheimer’s disease. Am J Manag Care. 2011;17(Suppl 13):S346–55.

3. Parsons CG, Danysz W, Dekundy A, Pulte I. Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer’s disease. Neurotox Res. 2013;24:358–69.

4. Atri A, Rountree SD, Lopez OL, Doody RS. Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer’s disease: comparison of efficacy and effectiveness studies. Neurodegener Dis. 2012;10:170–4.

5. Cummings JL, Morstorf T, Zhong K. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther. 2014;6:37.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial;Neurology Clinical Practice;2024-04

2. Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer’s disease;Alzheimer's Research & Therapy;2024-02-29

3. Charting the African Neuroethics Discourse: Ethical Issues of Neuroscience in Africa;2024

4. Decision making in clinical trials: Interim analyses, innovative design, and biomarkers;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2023-10

5. A call for clinical trial globalization in Alzheimer's disease and related dementia;Alzheimer's & Dementia;2023-02-25